- US12605537utility2026Implantable Medical Device for Use with or Having Recording Electrode0 cites
- US12607638utility2026Methods of Treating Inflammatory and Autoimmune Diseases with Natalizumab0 cites
- US12565504utility2026Spirocyclic O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase Inhibitors0 cites
- US12565500utility2026Substituted Pyrrolo[1,2-b]pyridazines and Pyrrolo[2,1-f][1,2,4]triazines as Btk Inhibitors0 cites
- US12551669utility2026Medical System Including Two Access Ports0 cites
- US12486289utility2025Tricyclic Compounds as Glycogen Synthase Kinase 3 (GSK3) Inhibitors and Uses Thereof0 cites
- US12472171utility2025Methods for Treating Hypercholesterolemia0 cites
- US12467929utility2025Methods of Detecting UBE3A Protein0 cites
- US12429487utility2025Neurofilament Protein for Guiding Therapeutic Intervention in Amyotrophic Lateral Sclerosis0 cites
- US12421224utility2025Azetidinyl O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase Inhibitors0 cites
- US12404263utility2025ASK1 Inhibiting Agents0 cites
- US12391697utility2025Condensed Bi-heterocycles as Inhibiting Agents for Bruton's Tyrosine Kinase0 cites
- US12392784utility2025Method of Assessing Risk of PML0 cites
- US12385925utility2025Anti-vla-4 Related Assays0 cites
- US12372470utility2025Use of Raman Spectroscopy to Monitor Culture Medium0 cites
- US12357569utility2025Infusing Drug Solution Directly Into Brain Fluid0 cites
- US12345703utility2025Assay for JC Virus Antibodies0 cites
- US12275728utility2025O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase Inhibitors0 cites
Page 1 of 3Next →